Evidence map›Paper›PMID 41156584›Full record

ArticlePathogens (Basel, Switzerland)2025

Significant Mortality Reduction from Severe

Filip Glavač, Lucija Dragošević, Josip Begovac, Marko Kutleša, Anita Atelj, Martina Vargović, Šime Zekan, Đivo Ljubičić, Ana Čičmak, Marija Santini

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Filip GlavačDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.
Lucija DragoševićSchool of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Josip BegovacDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0003-2641-4327
Marko KutlešaDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.
Anita AteljDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.
Martina VargovićDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.
Šime ZekanDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.
Đivo LjubičićSchool of Medicine, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0001-7071-9078
Ana ČičmakDepartment for Mycology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.
Marija SantiniDepartment for Infections in Immunocompromised, University Hospital for Infectious Diseases Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-8492-1418

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsPneumocystis cariniiPneumonia, PneumocystisAdultCroatiaFemaleHumansIntensive Care UnitsMaleMiddle AgedRetrospective Studiesacquired immunodeficiency syndromeextracorporeal membrane oxygenationHIVintensive care unitsinvasive mechanical ventilationPneumocystis jiroveciipneumonia

Identifiers

PMID41156584
PMCPMC12567465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.